Диссертация (1140247), страница 17
Текст из файла (страница 17)
Kandulski A, Jechorek D, Caro C, et al. Histomorphological differentiation ofnon-erosive reflux disease and functional heartburn in patients with PPIreffactory heartburn. Aliment Pharmacol Ther 2013; 38:643-651.101112. Katz PO, Gerson LE, Vela MF. Guidelines for the diagnosis and management ofgastroesophageal reflux disease. Am J Gastroenterol 2013; 108:308-328; quiz329.113.
Kern M, Hofmann C, Hyde J, et al. Characterization of the cerebral corticalrepresentation of heartburn in GERD patients. Am J Physiol Gastrointest LiverPhysiol 2004; 286:G174-G181.114. Kethman W, Hawn M. New approaches to gastroesophageal reflux disease. JGastrointest Surg. 2017 Sep; 21(9):1544-1552.115. Kirchner A, Stefan H, Bastian K, et al. Vagus nerve stimulation suppresses painbut has limited effects on neurogenic inflammation in humans.
Eur J Pain 2006;10:449-455.116. Klare P, Meining A, von Delius S, et al. Argon plasma coagulation of gastricinlet patches for the treatment of globus sensation: it is an effective therapy inthe long term. Digestion 2013; 88:165-171.117. Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease.Gut 2008; 57:674-683.118. Knowles CH, Aziz Q.
Basic and clinical aspects of gastrointestinal pain. Pain2009; 141:191-209.119. Kushnir V, Sayuk GS, Gyawali CP. Multiple rapid swallow responses segregateachalasia subtypes on high-resolution manometry. Neurogastroenterol Motil2012; 24:1069-e1561.120. Kushnir VM, Sathyamurthy A, Drapekin J, et al. Assessment of concordance ofsymptom reflux association tests in ambulatory pH monitoring.
AlimentPharmacol Ther 2012.121. Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, Naliboff BD. TheVisceral Sensitivity Index: development and validation of a gastrointestinalsymptom-specific anxiety scale. Aliment Pharmacol Ther. 2004 Jul 1; 20(1):8997.102122. Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD.
The central role ofgastrointestinal-specific anxiety in irritable bowel syndrome: further validationof the visceral sensitivity index. Psychosom Med. 2007 Jan; 69(1):89-98.123. Lee BE, Kim GH. Globus pharyngeus: a review of its etiology, diagnosis andtreatment. World J Gastroenterol 2012; 18:2462-2471.124. Lee H, Lee SK, Park JC, et al. Effect of acid swallowing on esophagealcontraction in patients with heartburn related to hypersensitivity.
J GastroenterolHepatol 2013; 28: 84-89.125. Lee KJ, Kwon HC, Cheong JY, Cho SW. Demographic, clinical, andpsychological characteristics of the heartburn groups classified using the RomeIII criteria and factors associated with the responsiveness to proton pumpinhibitors in the gastroesophageal reflux disease group.
Digestion 2009; 79:1316.126. Lee SW, Chang CS, Lien HC, Peng YC, Wu CY, Yeh HZ. Impact ofoverlapping functional gastrointestinal disorders on the presentation and qualityof life of patients with erosive esophagitis and nonerosive reflux disease. MedPrinc Pract. 2015; 24(5):491-5.127.
Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlapsbetween gastroesophageal reflux disease, dyspepsia and irritable bowelsyndrome: a population-based study. Digestion. 2009; 79:196-201.128. Lind CD. Dysphagia: evaluation and treatment. Gastroenterol Clin North Am2003; 32:553-575.129. Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findingsamong 50-79-year-old men and women in an urban population.
Dysphagia 1991;6:187-192.130. Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum ofgastroesophageal reflux: a population-based study in Olmsted County,Minnesota. Gastroenterology 1997; 112:1448-1456.103131. Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms inindividuals with irritable bowel syndrome in the community: a meta-analysis.Am J Gastroenterol. 2012 Dec; 107(12):1793-801.132.
Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilicesophagitis: evidence-based statements and recommendations for diagnosis andmanagement in children and adults. United European Gastroenterol J. 2017;5:335–358.133. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis:clinical and functional correlates and further validation of the Los Angelesclassification. Gut 1999; 45:172-180.134. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients withpersistent symptoms despite acid suppressive therapy: a multicentre study usingcombined ambulatory impedance-pH monitoring.
Gut 2006; 55:1398-1402.135. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease(NERD) – acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-545.136. Martinucci I, de Bortoli N, Savarino E, et al. Esophageal baseline impedancelevels in patients with pathophysiological characteristics of functional heartburn.Neurogastroenterol Motil. 2014; 26:546–555.137. Matthews PJ, Aziz Q, Facer P, et al. Increased capsaicin receptor TRPV1 nervefibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004;16:897-902.138. Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view ofIBS. Nat Rev Gastroenterol Hepatol.
2015 Oct; 12(10):592-605.139. Min YW, Lim SW, Lee JH, Lee HL, Lee OY, Park JM, Choi MG, Rhee PL.Prevalence of extraesophageal symptoms in patients with gastroesophagealreflux disease:amulticenterquestionnaire-based study inNeurogastroenterol Motil. 2014 Jan; 20(1):87-93.104Korea. J140. Mitchell CM, Drossman DA.
Survey of the AGA membership relating topatients with functional gastrointestinal disorders. Gastroenterology 1987;92:1282-1284.141. Molina-Infante J, Bredenoord AJ, Cheng E, et al. PPI-REE Task Force of theEuropean Society of Eosinophilic Oesophagitis (EUREOS) Proton pumpinhibitor-responsive oesophageal eosinophilia: an entity challenging currentdiagnostic criteria for eosinophilic oesophagitis.
Gut. 2016; 65:524–531.142. Mönnikes H, Heading RC, Schmitt H, Doerfler H. Influence of irritable bowelsyndrome on treatment outcome in gastroesophageal reflux disease. World JGastroenterol. 2011 Jul 21; 17(27):3235-41.143. Moser G, Wenzel-Abatzi ТА, Stelzeneder M, et al. Globus sensation: pharyngoesophageal function, psychometric and psychiatric findings, and follow-up in 88patients. Arch Intern Med 1998; 158:1365-1373.144. Mousavi S, Tosi J, Eskandarian R, et al. Role of clinical presentation indiagnosing reflux-related non-cardiac chest pain.
J Gastroenterol Hepatol 2007;22:218-221.145. Mudipalli RS, Remes-Troche JM, Andersen L, Rao SS. Functional chest pain:esophageal or overlapping functional disorder. J Clin Gastroenterol. 2007 Mar;41(3):264-9.146. Nam SY, Ryu KH, Park BJ. Irritable bowel syndrome is associated withgastroesophagealrefluxsymptombutnoterosiveesophagitisJNeurogastroenterol Motil. 2013 Oct; 19(4):521-31.147.
Nasr I, Attaluri A, Hashmi S, Gregersen H, Rao SS. Investigation of esophagealsensationandbiomechanicalpropertiesinfunctionalchestpain.Neurogastroenterol Motil 2010; 22:520-6, e116.148. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlapbetween IBS and GERD: a systematic review of the literature.
Dig Dis Sci. 2006;51:2113–2120.105149. Neumann H, Monkemuller K, Kandulski A, Malfertheiner P. Dyspepsia and IBSsymptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis. 2008;26(3):243-7.150. Nevens F, Janssens J, Piessens J, et al. Prospective study on prevalence ofesophageal chest pain in patients referred on an elective basis to a cardiac unitfor suspected myocardial ischemia.
Dig Dis Sci 1991; 36:229-235.151. Niu XP, Yu BP, Wang YD, Han Z, Liu SF, He CY, Zhang GZ, Wu WC. Riskfactors for proton pump inhibitor refractoriness in Chinese patients with nonerosive reflux disease. World J Gastroenterol. 2013 May 28; 19(20):3124-9.152. Nojkov B, Rubenstein JH, Adlis SA, et al. The influence of co-morbid IBS andpsychological distress on outcomes and quality of life following PPI therapy inpatients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;27:473-482153.
Obekli T, Akyuz F, Akyuz U, Arici S, İliaz R, Gokturk S, Evirgen S, Cavus B,Karaca C, Demir K, Besisik F, Kaymakoglu S. Belching in Irritable BowelSyndrome: An Impedance Study. J Neurogastroenterol Motil. 2017 Jul 30;23(3):409-414.154. Ofman JJ, Gralnek IM, Udani J, et al. The cost-effectiveness of the omeprazoletest in patients with noncardiac chest pain. Am J Med 1999; 107:219-227.155. Pan HY, Xiang XL, Lyu SZ, Xie XP, Hou XH.
A comparison of clinicalcharacteristics between non-erosive reflux disease and reflux esophagitis.Zhonghua Nei Ke Za Zhi. 2016 Jul 1; 55(7):510-4.156. Pandolfino JE, Kwiatek MA, Ho K, et al. Unique features of esophagogastricjunction pressure topography in hiatus hernia patients with dysphagia. Surgery2010; 147: 57-64.157.
Pasricha PJ. Neurogastroenterology: a great career choice for aspiringgastroenterologists thinking about the future. Gastroenterology 2011; 140:11261128.106158. Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.Clin Gastroenterol Hepatol 2014.159.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
